Immunomodulation in Pomalidomide, Dexamethasone, and Daratumumab-Treated Patients with Relapsed/Refractory Multiple Myeloma.
Clin Cancer Res
; 26(22): 5895-5902, 2020 11 15.
Article
in En
| MEDLINE
| ID: mdl-32928795
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thalidomide
/
Dexamethasone
/
Antibodies, Monoclonal
/
Multiple Myeloma
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2020
Document type:
Article
Country of publication:
United States